BioAffinity Technologies Reports First Quarter 2023 Financial Results

bioAffinity Technologies, Inc. , a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other diseases of the lung, today reported financial results for... | May 15, 2023

Related Keywords

Japan ,University Of Texas At San Antonio ,Texas ,United States ,Canada ,China ,Hong Kong ,India ,Mexico ,Australia ,Maria Zannes ,Precision Pathology Services ,European Union ,Affinity Technologies Inc ,Havas Health You ,Trademark Office ,Nasdaq ,Trinity Life Sciences ,Affinity Technologies ,Michael Dougherty ,Chief Financial ,Havas Health ,Nasdaq Stock Market ,Compositions Useful ,Respiratory Research ,Modified Beads ,Compensation Controls ,Visualized Experiments ,Cleveland Clinic ,Early Lung Cancer ,Affinity President ,Chief Executive Officer Maria Zannes ,Precision Pathology ,Condensed Consolidated Statements ,Bioaffinity Technologies ,Nc Stock Exchange ,News ,Information ,Press Release ,Ioaffinity ,Biotechnology ,Company ,Ddressing ,The ,Need ,Or ,Noninvasive ,Detection ,F ,Young ,Dancer ,End ,Mother ,Diseases ,Oday ,Eported ,Financial ,Esults Biaf Us09076w1099 ,